Skip to content

Study · Animal study (in vivo) · rat · 2014

3 results

Morphine attenuates testosterone response to central injection of kisspeptin in male rats.

Mahmoudi F, Khazali H, Janahmadi M

International journal of fertility & sterility8 Jul 2014Cited by 6 (Europe PMC)

Summary

BackgroundKisspeptin and naloxone stimulate the reproductive axis while morphine inhibits its function. We have investigated the effect of central injection of kisspeptin-10 on mean plasma testosterone concentration in morphine or naloxone pretreated rats.Materials and methodsIn this experimental study, 60 male Wistar rats that were divid- ed into 12 groups (n=5 per group) received saline, kisspeptin (1 nmol, ICV), naloxone (2 mg/kg, subcutaneously), morphine (5 or 10 mg/kg, sc) or co-administrations of kisspeptin, morphine and naloxone at 09:00 - 09:30. In the co-administrated groups, kisspeptin was injected 15 minutes following morphine or naloxone injections. Blood samples were collected 60 minutes following injections via the tail vein. Plasma testosterone concentration was measured by a rat testosterone ELISA kit.ResultsCentral injection of kisspeptin or subcutaneous injection of naloxone significantly increased the mean plasma testosterone concentration compared to saline while subcutaneous injections of different doses of morphine (5 or 10 mg/kg) significantly decreased testosterone compared to saline. The results revealed that morphine significantly attenuated the testosterone increase after kisspeptin injection compared to kisspeptin while a stimulatory additive effect was observed in the kisspeptin/naloxone group compared to either naloxone or kisspeptin.ConclusionMorphine and kisspeptin systems may interact with each other to control the hypothalamic-pituitary-gonadal (HPG) axis.
CC BYText from Europe PMC. Highlighted sentences are the source of results.

Results from this study3

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In male Wistar rats, central injection of kisspeptin‑10 significantly increased mean plasma testosterone compared with saline.

    In plain wordsIn male rats, kisspeptin‑10 injected into the brain raised blood testosterone more than saline did.

    Outcome
    IncreasePlasma testosterone after central kisspeptin-10
    Study

    ratn = 5

    Male Wistar rats
    Comparator
    Saline
    Outcome group
    Sex hormones and fertility · Endocrine and hormones
    Studied dose
    1 nmol · ICVAs given in this study (rat).

    Source sentences

    Summary
    Central injection of kisspeptin or subcutaneous injection of naloxone significantly increased the mean plasma testosterone concentration compared to saline
    1 context sentence
    Summary · context
    In this experimental study, 60 male Wistar rats that were divid- ed into 12 groups (n=5 per group) received saline, kisspeptin (1 nmol, ICV), naloxone (2 mg/kg, subcutaneously), morphine (5 or 10 mg/kg, sc) or co-administrations of kisspeptin, morphine and naloxone at 09:00 - 09:30.

Studies that did not test the peptide alone2

In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Kisspeptin-10.

  1. 02AnimalNot a test of Kisspeptin-10 aloneAnimal study (in vivo)Efficacy outcome

    In male Wistar rats, morphine significantly attenuated the testosterone increase after kisspeptin‑10 compared with kisspeptin alone.

    In plain wordsIn male rats, morphine reduced the testosterone rise caused by kisspeptin‑10 compared with kisspeptin alone.

    Outcome
    DecreaseTestosterone response to kisspeptin-10 with morphine pretreatment
    Study

    ratn = 5

    Male Wistar rats
    Comparator
    Kisspeptin alone
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    morphine significantly attenuated the testosterone increase after kisspeptin injection compared to kisspeptin
    1 context sentence
    Summary · context
    In this experimental study, 60 male Wistar rats that were divid- ed into 12 groups (n=5 per group) received saline, kisspeptin (1 nmol, ICV), naloxone (2 mg/kg, subcutaneously), morphine (5 or 10 mg/kg, sc) or co-administrations of kisspeptin, morphine and naloxone at 09:00 - 09:30.

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

  2. 03AnimalNot a test of Kisspeptin-10 aloneAnimal study (in vivo)Efficacy outcome

    In male Wistar rats, kisspeptin‑10 plus naloxone produced a stimulatory additive effect on testosterone compared with either naloxone or kisspeptin‑10 alone.

    In plain wordsIn male rats, kisspeptin‑10 together with naloxone raised testosterone more than either one alone.

    Outcome
    IncreaseTestosterone with kisspeptin-10 plus naloxone
    Study

    ratn = 5

    Male Wistar rats
    Comparator
    Naloxone alone or kisspeptin-10 alone
    Outcome group
    Sex hormones and fertility · Endocrine and hormones

    Source sentences

    Summary
    a stimulatory additive effect was observed in the kisspeptin/naloxone group compared to either naloxone or kisspeptin.
    1 context sentence
    Summary · context
    In this experimental study, 60 male Wistar rats that were divid- ed into 12 groups (n=5 per group) received saline, kisspeptin (1 nmol, ICV), naloxone (2 mg/kg, subcutaneously), morphine (5 or 10 mg/kg, sc) or co-administrations of kisspeptin, morphine and naloxone at 09:00 - 09:30.

    In this study, Kisspeptin-10 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Kisspeptin-10.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 09:43 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.